-
441
Immunostimulatory Effects of Guanine-Quadruplex Topologies as Scaffolds for CpG Oligodeoxynucleotides
Published 2025-01-01Subjects: Get full text
Article -
442
Altered expression of miRNA profile in peripheral blood mononuclear cells following the third dose of inactivated COVID-19 vaccine
Published 2025-01-01Subjects: Get full text
Article -
443
Immunoglobulin M response in largemouth bass (Micropterus salmoides) following ranavirus infection
Published 2025-01-01Subjects: Get full text
Article -
444
SARS-CoV-2 SPIKE Antibody Levels can Indicate Immuno-Resilience to Re-infection: a Real-World Study
Published 2024-12-01Subjects: Get full text
Article -
445
-
446
-
447
-
448
-
449
-
450
The probable progression of Epstein-Barr virus (EBV) to chronic active EBV/reactivation weakens the immune response and stimulates Cryptococcus neoformans infection, which invariably proves fatal: a case report and review of the literature
Published 2025-01-01“…We have reported here the fatal outcome of Epstein-Barr virus (EBV) infection in a 58-year-old male who had probably developed reactivation/chronic active EBV (CAEBV) which gave rise to various neurological deficits, pancytopenia, and a lower CD4 count in the patient. The decreased immune response helped Cryptococcus neoformans (C. neoformans) to manifest a disseminated infection. …”
Get full text
Article -
451
Identification of Bacterial Lipopolysaccharide-Associated Genes and Molecular Subtypes in Autism Spectrum Disorder
Published 2025-01-01Subjects: Get full text
Article -
452
A new paradigm for cancer immunotherapy: targeting immunogenic cell death-related noncoding RNA
Published 2025-01-01Subjects: Get full text
Article -
453
-
454
A high-valence bismuth(V) nanoplatform triggers cancer cell death and anti-tumor immune responses with exogenous excitation-free endogenous H2O2- and O2-independent ROS generation
Published 2025-01-01“…NaBiVO3-PEG intratumorally administered initiates robust therapeutic efficacies against both primary and distant tumors and activates systemic immune responses to combat tumor metastasis. NaBiVO3-PEG intravenously administered can efficiently accumulate at the tumor site for further real-time computed tomography monitoring, immunotherapy, or alternative synergistic immune-radiotherapy. …”
Get full text
Article -
455
Longitudinal immunogenicity cohort study of SARS-CoV-2 mRNA vaccines across individuals with different immunocompromising conditions: heterogeneity in the immune response and crucial role of Omicron-adapted booster dosesResearch in context
Published 2025-03-01“…Here, we determined and compared in a longitudinal study the immune response elicited by SARS-CoV-2 vaccination across different groups of individuals who are immunocompromised. …”
Get full text
Article -
456
-
457
-
458
-
459
Therapeutic plasma exchange accelerates immune cell recovery in severe COVID-19
Published 2025-01-01Subjects: Get full text
Article -
460
Characteristics and clinical significance of immune cells in omental milky spots of patients with gastric cancer
Published 2025-01-01Subjects: Get full text
Article